Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15252159rdf:typepubmed:Citationlld:pubmed
pubmed-article:15252159lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C1524112lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0041199lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0242485lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0006560lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:15252159lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:15252159pubmed:issue9lld:pubmed
pubmed-article:15252159pubmed:dateCreated2004-8-9lld:pubmed
pubmed-article:15252159pubmed:abstractTextCardiac Troponin I (cTnI) levels are considered an important diagnostic tool in acute coronary events. They could be of predictive value in haemodialysis (HD) patients. However, the relationship between cTnI and the HD-induced inflammatory state remains unclear. The aim of this study was to explore the prognostic relevance to all-cause and cardiovascular mortalities in HD patients of cTnI, in combination with highly sensitive C-reactive protein (hs-CRP) levels.lld:pubmed
pubmed-article:15252159pubmed:languageenglld:pubmed
pubmed-article:15252159pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252159pubmed:citationSubsetIMlld:pubmed
pubmed-article:15252159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252159pubmed:statusMEDLINElld:pubmed
pubmed-article:15252159pubmed:monthSeplld:pubmed
pubmed-article:15252159pubmed:issn0931-0509lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:CristolJean-P...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:DelcourtCécil...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:CanaudBernard...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:JaussentIsabe...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:DupuyAnne-Mar...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:BoulierAlexan...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:TerrierNathal...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:MauriceFranço...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:RivoryJean-Pi...lld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:ChalabiLotfiLlld:pubmed
pubmed-article:15252159pubmed:authorpubmed-author:BoularanAnne-...lld:pubmed
pubmed-article:15252159pubmed:issnTypePrintlld:pubmed
pubmed-article:15252159pubmed:volume19lld:pubmed
pubmed-article:15252159pubmed:ownerNLMlld:pubmed
pubmed-article:15252159pubmed:authorsCompleteYlld:pubmed
pubmed-article:15252159pubmed:pagination2313-8lld:pubmed
pubmed-article:15252159pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:meshHeadingpubmed-meshheading:15252159...lld:pubmed
pubmed-article:15252159pubmed:year2004lld:pubmed
pubmed-article:15252159pubmed:articleTitleMeasurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.lld:pubmed
pubmed-article:15252159pubmed:affiliationBiochemistry Laboratory, Hôpital Lapeyronie, 371 Av. Doyen Gaston Giraud, 34295 Montpellier cedex 5, France. jp-cristol@chu-montpellier.frlld:pubmed
pubmed-article:15252159pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15252159pubmed:publicationTypeComparative Studylld:pubmed